• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION SMARTFREEZE; CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FIBRILLATION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION SMARTFREEZE; CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FIBRILLATION Back to Search Results
Lot Number PXC00425
Medical Device Problem Code Temperature Problem (3022)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 02/05/2024
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
It was indicated that the device will not be returned for evaluation.If there is any further relevant information obtained, a supplemental medwatch will be filed.
 
Event or Problem Description
This event is being reported for aborted/cancelled procedure with a patient under sedation.During a cryo ablation with polarx fit a smartfreeze cryo console was selected for use.Following a gas bottle exchange, no temperatures recorded reached lower than -30 degrees.Flow and pressure during ablation where about 9000 and 590.Troubleshooting includes restarting the console, disconnect and reconnect the gas bottle, and exchange of the gas cable.The issue could not be resolved.The patient was under general anesthesia when the procedure was cancelled/ rescheduled.The device is not expected to return the physician request onsite service.
 
Additional Manufacturer Narrative
Device technical analysis: upon receipt at boston scientific's post market laboratory the returned flowmeter was tested by connecting to gold system and performing the flowmeter verification test.It was found that the flowmeter was out of calibration, reading higher than it should.This can contribute to warmer balloon temperatures.
 
Event or Problem Description
This event is being reported for aborted/cancelled procedure with a patient under sedation.During a cryo ablation with polarx fit a smartfreeze cryo console was selected for use.Following a gas bottle exchange, no temperatures recorded reached lower than -30 degrees.Flow and pressure during ablation where about 9000 and 590.Troubleshooting includes restarting the console, disconnect and reconnect the gas bottle, and exchange of the gas cable.The issue could not be resolved.The patient was under general anesthesia when the procedure was cancelled/ rescheduled.The device is not expected to return the physician request onsite service.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SMARTFREEZE
Common Device Name
CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FIBRILLATION
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
4100 hamline avenue north
saint paul MN 55112 5798
Manufacturer Contact
timothy degroot
4100 hamline avenue north
dc a330
saint paul, MN 55112
6515826168
MDR Report Key18735986
Report Number2124215-2024-08516
Device Sequence Number20428111
Product Code OAE
UDI-Device Identifier08714729992691
UDI-Public08714729992691
Combination Product (Y/N)N
Initial Reporter CountryGM
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Other,Foreign,Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 07/16/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Lot NumberPXC00425
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Follow-Up
Initial Date Received by Manufacturer 02/05/2024
Supplement Date Received by Manufacturer06/18/2024
Initial Report FDA Received Date02/19/2024
Supplement Report FDA Received Date07/16/2024
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured04/01/2022
Is the Device Labeled for Single Use? (Y/N) No
Usage of Device Unknown
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient SexUnknown
-
-